- Home
- PRME vs IFN Comparison
PRME vs IFN Comparison
Compare PRME & IFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRME | IFN |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 540.6M |
| IPO Year | 2022 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PRME | IFN |
|---|---|---|
| Price | $3.42 | $11.81 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $7.56 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 260.2K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,632,000.00 | N/A |
| Revenue This Year | $12.41 | N/A |
| Revenue Next Year | $52.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 55.28 | N/A |
| 52 Week Low | $1.11 | $10.84 |
| 52 Week High | $6.94 | $16.60 |
Technical Indicators
Market Signals| Indicator | PRME | IFN |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 50.56 |
| Support Level | $3.17 | $10.84 |
| Resistance Level | $3.94 | $14.08 |
| Average True Range (ATR) | 0.25 | 0.22 |
| MACD | 0.01 | 0.14 |
| Stochastic Oscillator | 47.17 | 96.04 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About IFN India Fund Inc. (The)
India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing in the equity securities of Indian companies. The company's portfolio is a non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities, and others. Geographically, all the business activity functions through the market of the United States.